The Use of Nonselective Beta Blockers for Treatment of Portal Hypertension
- PMID: 29230139
- PMCID: PMC5718179
The Use of Nonselective Beta Blockers for Treatment of Portal Hypertension
Conflict of interest statement
Dr Garcia-Tsao has no relevant conflicts of interest to disclose.
References
-
- Bang UC, Benfield T, Hyldstrup L, Jensen JE, Bendtsen F. Effect of propranolol on survival in patients with decompensated cirrhosis: a nationwide study based Danish patient registers. Liver Int. 2016;36(9):1304–1312. - PubMed
-
- Chirapongsathorn S, Valentin N, Alahdab F, et al. Nonselective β-blockers and survival in patients with cirrhosis and ascites: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2016;14(8):1096–1104.e9. - PubMed
-
- Garcia-Tsao G. Beta blockers in cirrhosis: the window re-opens. J Hepatol. 2016;64(3):532–534. - PubMed
-
- Garcia-Tsao G, Abraldes JG, Berzigotti A, Bosch J. Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the Study of Liver Diseases. Hepatology. 2017;65(1):310–335. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources